# Cardiovascular Events in GnRH Agonist vs. Antagonist

> **NCT04182594** · PHASE2 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Hormone Sensitive Prostate Cancer
- Prostate Cancer
- Cardiac Event

## Interventions

- **DRUG:** Degarelix
- **DRUG:** GnRH agonist

## Key facts

- **NCT ID:** NCT04182594
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-17
- **Primary completion:** 2023-01-17
- **Final completion:** 2023-01-17
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04182594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04182594, "Cardiovascular Events in GnRH Agonist vs. Antagonist". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04182594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*